| Financial Year |
March 31 2023 |
| Monetary Funds |
838,456,680.09 |
| Held-for-trading Financial Assets |
42,655,830.17 |
| Notes Receivable |
2,801,482.55 |
| Accounts Receivable |
747,735,354.35 |
| Advances to Suppliers |
46,570,727.22 |
| Other Receivables |
36,922,757.63 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
399,064,059.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
15,221,196.14 |
| Other Current Assets |
21,798,427.08 |
| Total Current Assets |
2,236,379,501.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
42,600,182.42 |
| Long-term Equity Investment |
76,384,376.05 |
| Investment Properties |
-- |
| Fixed Assetes |
111,818,360.45 |
| Under-construction Projects |
14,826,049.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
9,660,204.97 |
| R&D expenses |
1,260,660.19 |
| Goodwill |
31,272,070.24 |
| Long-Term Deferred and Prepaid Expenses |
7,359,217.58 |
| Deferred Income Tax Assets |
60,308,157.38 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
560,897,368.99 |
| Total Assets |
2,797,276,870.29 |
| Short-Term Loans |
108,758,948.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
800,895.38 |
| Accounts Payable |
606,141,679.25 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
82,765,840.51 |
| Taxes Payable |
46,083,614.65 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
33,265,510.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,208,974.93 |
| Other Current Liabilities |
2,168,168.80 |
| Sub-Total of Current Liabilities |
993,242,608.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,088,349.04 |
| Deferred Income Tax Liabilities |
4,995,122.77 |
| Other Non-Current Liabilities |
175,000.00 |
| Sub-Total of Non-Current Liabilities |
9,697,896.70 |
| Total Liabilities |
1,002,940,505.55 |
| Paid-In Capital(Or Share Stock) |
881,658,531.00 |
| Capital Surplus |
2,238,381,618.66 |
| Surplus Reserve |
42,053,024.73 |
| LESS:Treasury Stock |
1,857,600.00 |
| Undistributed Profits |
-1,284,741,529.64 |
| Minority Stockholder's Interest |
-12,722,315.20 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,807,058,679.94 |
| Owner's Equity（Stockholder's Equity） |
1,794,336,364.74 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,797,276,870.29 |
